Topic: New Science and Tech and Precision Med

Is trust the key success factor for decentralized clinical trials?
By Cesar Villalta
Stas Verberkt
June 27, 2022
Four ways to successfully enable trust in decentralized clinical trials to increase participation, improve results and secure data. Accenture describes how.
Pharma-tech partner growth: Are you missing out?
By Pervaise Khan
Jeffrey Berry
June 20, 2022
We talk about the common pitfalls pharma companies can avoid when engaging in pharma-tech partnerships and imperatives for success. Accenture explores more.
Three ways cloud can bring out the best in your employees
By Geoff Schmidt
Shira Macagon
April 26, 2022
Change enablement professionals are turning to human-centric transformations to create a better work culture with Accenture cloud for their clients. Read more.
What’s the key to affordable care in Africa?
By Natasha Sunderji
January 10, 2022
Accenture participated in the launch of the Novartis virtual innovation hub which will focus on accelerating digital health in sub-Saharan Africa. Read more.
Accelerating growth through tech partnerships
By Pervaise Khan
Jeffrey Berry
January 3, 2022
Accenture explores how technology can dramatically accelerate progress in life sciences. Read more.
Digital Health: Put the care back in healthcare
By Ted Boyle
December 6, 2021
Accenture's Ted Boyle explores how healthcare industries can put the care back in healthcare. Read more.
Weaving the digital thread for life sciences
By Barry Heavey
David Twohig
November 15, 2021
Accenture’s digital thread works to tackle the ongoing challenges within life sciences through greater connectivity & data visibility. Read more.
Making the impossible possible: a bold formula for change at Galien Forum 2021
By Petra Jantzer
November 5, 2021
Accenture's Petra Jantzer co-moderated the Galien Golden Jubilee Forum and discussed critically important lessons learned from COVID-19. Read more.
Change the economic bond with biopharma customers
By Ray Pressburger
September 20, 2021
Accenture describes three ways to transform the economic relationship with biopharma customers. Read more.
A new economic reality is challenging profitability
By Elizabeth Ferguson-LaChance
September 7, 2021
Accenture explores how changes in personalized, complex medicine are challenging health systems' ability to afford the care that populations require. Read more.
Biopharma: The consumer will see you now
By Ted Boyle
August 23, 2021
Accenture explores biopharma companies consumer populations to raise brand awareness & build a trusted relationship that can last a lifetime. Read more.
Biopharma: Partner with patients for life
By Ted Boyle
June 21, 2021
Accenture's Ted Boyle explores the rapid proliferation of health-related apps and how anticipating the needs of consumer builds brand awareness. Read more.
Resilience in the face of ransomware threats
By Cesar Villalta
June 1, 2021
Accenture explains how cybersecurity leaders can counter ransomware challenges while strengthening defenses across people, processes and technology. Read more.
Time for a cell & gene bottleneck shift
By Sanjay Srivastava
May 10, 2021
Accenture reveals the accelerated development in gene therapies is causing a fundamental shift in the traditional biopharmaceutical business model. Read more.
Biopharma’s Journey: Lessons learned from leaders
By Kingston Smith
April 19, 2021
Accenture's Kingston Smith explores the seven tenets of data transformation and lessons learned from leaders in biopharma. Read more.
Reimagining the target selection process
By Jens Hoefkens
March 15, 2021
Through our work with Google on the Target ID Solution, Accenture is reimagining the target selection process. Read more.
Biopharma’s Journey: Four pillars to data-driven success
By Kingston Smith
March 8, 2021
Accenture's Kingston Smith explores four pillars critical for biopharma companies to become truly data-driven enterprises. Read more.
The case for going all in on cloud in life sciences
By Geoff Schmidt
February 7, 2021
Accenture's blog shares six strategies for cloud adoption success for life sciences companies. Read more.
Lab transformation strategy: The digital thread
By Barry Heavey
January 25, 2021
Accenture's Barry Heavey explores three clear phases and steps to enable transformation of the digital laboratory. Learn more.
Welcome to 2021: The year of the vaccine?
By Stuart Henderson
Andrew Meade
January 18, 2021
Accenture's blog explores what to expect this new year 2021 for COVID-19 vaccine supply chains and employers planning a return to the workplace. Explore more.
Biopharma’s journey: Finding data-driven success
By Kingston Smith
December 15, 2020
Accenture's Kingston Smith shares three "Horizons" for becoming a truly data-driven biopharma company. Read more.
Controlling quality by managing data
By Barry Heavey
December 7, 2020
Accenture's blog reveals companies can use data to streamline development and deliver better patient outcomes by investing in digital. Read more.
Three trends driving virtual oncology
By Mathias Ganter
November 27, 2020
Accenture's blog explains how coronavirus (COVID-19) has changed the oncologist-patient relationship for better cancer care. Read more.
Pathways to scale AI in biopharma
By Chad Vaske
Kingston Smith
October 27, 2020
Accenture's blog describes five strategies for overcoming barriers to scale AI in biopharma. Read more.
Scaling AI in biopharma for transformation and growth
By Chad Vaske
Kingston Smith
September 7, 2020
Accenture's blog reveals strategies for successfully adopting transformation in biopharma as AI is the key for survival and growth. Read more.
Patients are people first
By Brad Michel
August 17, 2020
Accenture's Brad Michel discusses how patients are adapting to coronavirus (COVID-19) and the permanent changes in their behavior. Read more.
Clinical decision support tools for oncology
By Bogdan Boris, PhD
Dr. Sandra Dietschy-Kuenzle
July 27, 2020
Accenture's blog explains how Clinical decision support tools in oncology will fundamentally change the way cancer patients are treated. Read more.
How life sciences companies can outmaneuver disruption
By Stuart Henderson
May 8, 2020
Accenture's Stuart Henderson discusses how life sciences companies can outmaneuver coronavirus (COVID-19) disruption. Read more.
The Great Divide: The world of scientists in and out of the lab
By Brian Potter
February 13, 2020
Brian Potter discusses what’s happening within the life sciences laboratory. Learn more.
Cell and gene therapy: The next wave of discovery
By Sanjay Srivastava
January 16, 2020
Accenture’s Sanjay Srivastava discusses how to overcome the challenges of cell and gene therapy. Learn more.
Life sciences is transforming through technology
By Andy Greenberg
December 17, 2019
Accenture's Andy Greenberg discusses life sciences technology trends that are transforming the future of life sciences through technology. Read more.
California: A window into talent and growth for life sciences
By Benoit Berthoux
December 11, 2019
Digital health is transforming the global life sciences sector and life sciences companies have an opportunity to benefit from this trend. Read more.
New Science: Biopharma’s new growth machine
By Stuart Henderson
Sanskriti Thakur
October 7, 2019
Accenture blog explores the signs of compressive disruption and how New Science can help biopharma companies capitalize on transformation. Learn more.
View All
ALL TOPICS PAGES
Subscription Center
Subscribe to Life Sciences Blog Subscribe to Life Sciences Blog
Subscribe